Micromet, will autoimmune Md., biopharmaceutical treatment host inflammation a that it for BETHESDA, announced company ... 2 -- MITI), cancer, May and developing /PRNewswire-FirstCall/ (Nasdaq: a proprietary novel, antibodies diseases, Inc. the today of ...
Read More...
3.7.08
Call - Conference to Inc. ... Discuss Host and to Webcast Forbes First Micromet,
Posted by
admin
at
Thursday, July 03, 2008